General Topics
No. | TOPIC |
---|---|
1 | Haematopoietic Stem Cells |
2 | Stem Cell Mobilization, Collection and Engineering |
3 | CAR-based Cellular Therapy – Preclinical |
4 | CAR-based Cellular Therapy – Clinical |
5 | Cellular Therapies other than CARs |
6 | Experimental Transplantation and Gene Therapy |
7 | New Drugs and Cell-based Immune Therapies |
8 | Non-haematopoietic Stem Cells and Regenerative Medicine |
Transplant-Specific Topics
no. | TOPIC |
---|---|
9 | Stem Cell Source |
10 | Stem Cell Donor |
11 | Graft-versus-host Disease – Preclinical and Animal Models |
12 | Graft-versus-host Disease – Clinical |
13 | Infectious Complications |
14 | Non-infectious Early Complications |
15 | Non-infectious Late Effects, Quality of Life and Fertility |
16 | Conditioning Regimens |
17 | Minimal Residual Disease, Tolerance, Chimerism and Immune Reconstitution |
18 | Paediatric Issues |
Disease-Specific Topics
no. | TOPIC |
---|---|
19 | Acute Leukaemia |
20 | Aplastic Anaemia |
21 | Autoimmune Diseases |
22 | Myeloproliferative Neoplasm |
23 | Haemoglobinopathy |
24 | Inborn Errors, Granulocyte and Osteoclast Disorders |
25 | Immunodeficiency Diseases and Macrophages |
26 | Lymphoma and Chronic Lymphocytic Leukaemia |
27 | Multiple Myeloma |
28 | Myelodysplastic Syndromes |
29 | Chronic Leukaemia and Other Myeloproliferative Disorders |
30 | Solid Tumours |
Other Topics
no. | TOPIC |
---|---|
31 | Data Management |
32 | Statistics |
33 | Quality Management |
34 | Patient Advocacy: Patients' Reported Outcome and Expectations |
35 | Psychological Issues |
36 | Pharmacology |
no. | TOPIC |
---|---|
37 | Care of the Carer (Healthcare Team and Caregiver) |
38 | Complementary Therapies |
39 | Donor Care |
40 | Ethical Issues |
41 | Impact of New Therapies on Patient Care |
42 | Education and Training |
43 | Management |
44 | Outpatient Developments and Ambulatory Care |
45 | Palliative and End-of-Life Care |
46 | Patient Safety and Standards of Care |
47 | Psycho-social Issues |
48 | Vaccination, Infection Control and Prevention |
49 | Quality of Life, Late Effects, Survivorship Care and Health Promotion |
50 | Symptom Management |
51 | CAR-T or Immune Effector Cells |
52 | Quality Management and JACIE |
53 | Transplant and CAR-T Coordination, and Follow-up |
54 | Advanced Nursing Practise |
55 | Nursing Research and Audit in Transplant and CAR-T |
56 | Digital Solutions in HSCT Nursing |
57 | Patient and Donor Information |
58 | Paediatric and AYA/TYA Care |
59 | Outreach Programmes for HSCT in LMICs |